UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2 Patent applications |
Patent application number | Title | Published |
20150344498 | Spiroisoxazoline Compounds Having an Activity Potentiating the Activity of an Antibiotic - The present invention concerns a spiroisoxazoline compound of general formula (I): | 12-03-2015 |
20150307471 | Saturated Nitrogen and N-Acylated Heterocycles Potentiating the Activity of an Active Antibiotic against Mycobacteria - The present invention concerns a compound of general formula (I): | 10-29-2015 |
20140309238 | FLUORALKYLCARBONYL-OXADIAZOLES - The present invention relates to compounds of Formula (I), wherein R1 is chosen among the following radicals: (II); (III); (IV), (V), (VI) (VII) and n=1 or 2 and m=1 or 2 with the proviso that m=2 when R1 is (VIII). The present invention also relates to the use thereof as drugs, more particularly in the treatment of mycobacterial infections and more particularly in the treatment of tuberculosis. | 10-16-2014 |
20110123981 | FTO GENE POLYMORPHISMS ASSOCIATED TO OBESITY AND/OR TYPE II DIABETES - The present invention provides means and methods for risk assessment and/or diagnosis and/or prognosis of obesity and/or type II diabetes in humans, based on the detection of nucleic acid biomarkers belonging to, or associated with, a set of SNPs in the fatso (FTO) gene. The present invention also provides means and methods for identifying a SNP haplotype associated with obesity and/or type II diabetes susceptibility in humans, for selecting pharmaceutical agents useful in prevention and/or treatment of obesity and/or type II diabetes in humans, for haplotyping the fatso (FTO) gene in humans. | 05-26-2011 |